Clopidogrel Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Clopidogrel Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A23197
Buy Now

Clopidogrel Prices March 2024

Product
Category Region Price
Clopidogrel Chemicals Korea $43,000/Ton
Clopidogrel Chemicals Chile $58,000/Ton


In the first quarter of 2024, the price of the clopidogrel in in Korea reached $43,000/Ton. Similarly, in Chile, the clopidogrel prices hit $58,000/Ton.

Clopidogrel Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Clopidogrel Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of clopidogrel pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of clopidogrel at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of clopidogrel price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing clopidogrel price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Clopidogrel Price Trend

Clopidogrel Market Analysis

The global clopidogrel market size reached US$ 12.4 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 30.1 Billion, at a projected CAGR of 10.40% during 2023-2032.

As the number of cases of cardiovascular diseases, specifically heart attacks and strokes, continues to rise, the demand for clopidogrel, a medication used to prevent blood clots, is also increasing, thereby driving the market growth. According to the Centers for Disease Control (CDC), 7 out of 10 U.S. deaths are caused by chronic disease, while roughly half of the country’s population has been diagnosed with a chronic illness, including heart disease, cancer, diabetes, AIDS, or other conditions classified by the medical community as preventable. This places clopidogrel among the most important medications for patients with high risk of thrombotic events, which are an essential component of cardiovascular treatment. Besides, the growing aging population, which is more susceptible to developing these conditions, is driving a high demand for these products. Ongoing advancements and current research in pharmaceutical formulations enhance clopidogrel’s clinical outcomes and risk-benefit ratio, increasing its utility among clinicians. These developments include the production of generic versions, making the medication more affordable and accessible to a larger number of patients. Additionally, approvals and reimbursement policies issued by organizations, particularly government bodies, play a significant role in the expansion of the market. For instance, Sanofi-aventis and Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for the antiplatelet agent PLAVIX(R) (clopidogrel bisulfate. This approval is aimed at reducing the overall mortality rate and the combined endpoint of re-infarction, stroke, or death in patients with acute ST-segment elevation myocardial infarction (STEMI). Also, the consciousness of health maintenance and the necessity to control cardiovascular consequences is increasing the demand for clopidogrel. The increasing awareness from governmental as well as non-governmental organizations’ sponsored healthcare campaigns ensures that users demand antiplatelet therapy. Factors related to economics like the growing investments on health care costs and advances in the health care industry, especially in the developing economies, are contributing to the expansion of the clopidogrel market. Furthermore, the diverse marketing strategies employed by different pharmaceutical companies involved in the distribution of clopidogrel are also enhancing market penetration.

Clopidogrel News

The report covers the latest developments, updates, and trends impacting the global clopidogrel market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in clopidogrel production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the clopidogrel price trend.

Latest developments in the Clopidogrel Industry:

  • In March 2024, CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd, announced that their Omalizumab biosimilar candidate BP11 has met the Phase 1 trial end points vis-à-vis the EU and US sourced reference product Xolair. The PK/PD trial was conducted in 165 healthy volunteers in Australia and New Zealand.
  • In May 2024, the U.S. Food and Drug Administration (FDA) accepted for Priority Review the supplemental Biologics License Application (sBLA) for the investigational use of Sarclisa (isatuximab) in combination with bortezomib, lenalidomide and dexamethasone (VRd) for the treatment of patients with transplant-ineligible newly diagnosed multiple myeloma (NDMM).

Product Description

Clopidogrel is an antiplatelet drug that is commonly prescribed to patients with cardiovascular conditions, including heart attacks and strokes, to prevent blood clot formation. This pharmaceutical agent has the mechanism of reducing the ability of platelets to coagulate and thus the risk of clot formation in arteries is minimized. Clopidogrel, a P2Y12 adenosine diphosphate (ADP) receptor antagonist, ensures long-term platelet inhibition. As an oral medication, it is convenient for patients to take and has been proven effective when combined with aspirin to enhance the antithrombotic effect. It is particularly valued for its prolonged prevention of further thrombotic episodes, making it a crucial component in the treatment of cardiovascular diseases.

Regional Coverage

The report provides a detailed analysis of the clopidogrel market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the clopidogrel price trend.

Global Clopidogrel Price

The report offers a holistic view of the global clopidogrel pricing trends in the form of clopidogrel price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of clopidogrel but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed clopidogrel demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Clopidogrel Price

In the European economy, the market price of clopidogrel was contributing to an increased demand of the product in the pharmaceutical sector. But they dropped significantly in the later periods due to enhancement in the supply side and demand restraints, along with contraction in degree of production downstream processing plants. Other factors influencing the changing prices in the region included rising shipping costs and the depreciation of the Euro. However, consumers benefited from an increased availability of commodities, which, in turn, reduced their supply as a primary price determinant.

Detailed price information for clopidogrel can also be provided for an extensive list of European countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


North America Clopidogrel Price

Initially, the prices for clopidogrel bisulfate in North America went up because of the increased demand for clopidogrel bisulfate among pharmaceutical organizations and shipping expenses. Nevertheless, the prices continually fell as the freight costs reduced and the value of US dollar increased, leading to better purchasing capacity and better availability of commodities. Intensified pricing mechanisms together with enhanced trade activities, also enhanced and reduced the volatility of the market prices at the end of the period.

Specific clopidogrel historical data within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Middle East and Africa Clopidogrel Price

The clopidogrel pricing trends in the Middle East and Africa are increasingly impacted by infrastructural developments and investments in the construction and transportation sectors. The region’s political climate and its effect on operational stability and security are also crucial in determining price trends. Additionally, the Middle East's strategic initiatives to diversify away from oil dependency and invest in mining and metal production capabilities are reshaping its market dynamics. In Africa, the availability of resources combined with foreign investment in mining projects heavily influences local and global clopidogrel supply and prices.

Region-wise data and information on specific countries within these regions can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Asia Pacific Clopidogrel Price

In Asia pacific, clopidogrel bisulfate prices at the commencement of the year hiked because of high demand of new export orders coupled with the high shipping expenses. However, prices started coming down since regional absorption was not as good and there were less international enquires. The rationalization of freight charges, the availability, and the stiff competition that was exhibited among the suppliers was another factor that boosted the decrease in price hence, increasing the trade activities and overall consumer price by the close of the period.

This clopidogrel price analysis can be expanded to include a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Latin America Clopidogrel Price

Latin America's clopidogrel market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in clopidogrel prices. Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting the region's ability to meet international demand consistently. Moreover, economic fluctuations and currency devaluation are critical factors that need to be considered when analyzing clopidogrel pricing trends in this region.

This comprehensive review can be extended to include specific countries within Latin America.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Clopidogrel
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Clopidogrel Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 


Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of clopidogrel pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting clopidogrel price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The clopidogrel price charts ensure our clients remain at the forefront of the industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Clopidogrel Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More